High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering a funding opportunity for high-priority research at the intersection of HIV and substance use through the National Institute on Drug Abuse (NIDA). This grant, identified as RFA-DA-25-024, aims to support innovative research projects that advance HIV/AIDS prevention, treatment, and outcomes for individuals using addictive substances, with a focus on addressing health disparities and enhancing perspectives from diverse populations. The total anticipated budget for this initiative is $3 million, with an expected number of 3-5 awards, and applications must be submitted between January 11, 2025, and February 12, 2027. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
Eligible Applicants
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.